In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...
The ambitious task on hand is apparent from the weighty title of the report – ‘Landscape Analysis on Alternatives to Animal Testing for Drug Development in India.’ That the report has the foreword by ...
現在アクセス不可の可能性がある結果が表示されています。
アクセス不可の結果を非表示にする